All posts by: Michael Zand

Abeona Therapeutics (ABEO) Reports FDA RMAT Designation for EB-101 Gene Therapy in Epidermolysis Bullosa – StreetInsider.com

Abeona Therapeutics (ABEO) Reports FDA RMAT Designation for EB-101 Gene Therapy in Epidermolysis BullosaStreetInsider.comSimilar to Breakthrough Therapy designation, the RMAT allows companies developing regenerative medicine therapies to work more clos… Continue reading

Waging war against the mosquito: Split-gene drive could hinder spread of Zika – Genetic Literacy Project

Genetic Literacy ProjectWaging war against the mosquito: Split-gene drive could hinder spread of ZikaGenetic Literacy ProjectSome advocacy groups, unhappy with this decision, have tried to raise suspicion that scientists who oppose the moratorium are i… Continue reading

Parents of child with rare genetic disorder place their hope in gene therapy, still in its early phases – Charleston Post Courier

Charleston Post CourierParents of child with rare genetic disorder place their hope in gene therapy, still in its early phasesCharleston Post CourierHis parents are placing their hope in the possibility of gene therapy. Though it has been shown to work… Continue reading

This company is the result of Nationwide Children’s reviving gene therapy in the US – Columbus Business First

Columbus Business First

This company is the result of Nationwide Children’s reviving gene therapy in the US Columbus Business First It’s the stuff of science fiction – replacing defective genes in the human body with new ones that will stop a debilitating disease. But it seems to be becoming reality at Michael Triplett’s new Columbus gene therapy company, which is having success …